Home LiteratureArticle Details
PMID: 367998 Published · ppublish English Journal Article

A new cephalosporin. SCE-963: 7-[2-(2-aminothiazol-4-yl)-acetamido]-3-[[[1-(2-dimethylaminoethyl)-1h-tetrazol-5-yl]-thio]methyl]ceph-3-em-4-carboxylic acid. Chemistry and structure-activity relationships.

The Journal of antibiotics ·Vol. 31 ·No. 12 ·1978-12-00 ·Pages 1262-71

Numata M, Minamida I, Yamaoka M, Shiraishi M, Miyawaki T, Akimoto H, Naito K, Kida M

Abstract

The synthesis and the in vitro and in vivo antimicrobial activities of a series of 7-[2-(2-aminothiazol-4-yl)acetamido]cephalosporins (1) having varied 3-substituents, such as methyl, hydroxymethyl, acetoxymethyl, pyridiniomethyl and heterocyclicthiomethyls, are described. The derivatives having five membered heterocyclicthiomethyls exhibited strong inhibitory activities against Gram-negative organisms including some strains of Escherichia coli and Proteus morganii which are insensitive to cefazolin and cephaloridine. Pronounced activities were noted with 7-[2-(2-aminothiazol-4-yl)-acetamido]-3-[[[1-(2-dimethylaminoethyl)-1H-tetrazol-5-yl]thio]methyl]ceph-3-em-4-carboxylic acid (1y; SCE-963).

MeSH Terms
Animals Bacteria/drug effects Cephalosporins/chemical synthesis,pharmacology,therapeutic use Escherichia coli Infections/drug therapy Male Mice Mice, Inbred ICR Microbial Sensitivity Tests Structure-Activity Relationship
Chemicals
Cephalosporins
Authors & Affiliations
8 authors, click to expand affiliations / ORCID
Numata M
Minamida I
Yamaoka M
Shiraishi M
Miyawaki T
Akimoto H
Naito K
Kida M
Article Info
Journal
The Journal of antibiotics
Abbr.
J Antibiot (Tokyo)
ISSN
0021-8820
Published
1978-12-00
Pages
1262-71
Language
English
Region
Japan
NLM ID
0151115
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com